Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2012
05/23/2012CN102471277A Microbiocidal heterocycles
05/23/2012CN102471274A 用于制备n-取代的吡啶*化合物的方法和物质 Pyridine * methods and materials are used instead of the compound prepared in n-
05/23/2012CN102470132A 二取代的[4-(5-氨基甲基-苯基)-哌啶-1-基]-1h-吲哚-3-基]-甲酮 Di-substituted [4- (5-amino-methyl - phenyl) - piperidin-1-yl] -1h- indol-3-yl] - methanone
05/23/2012CN102470130A Crystalline freebase forms of a biphenyl compound
05/23/2012CN102464654A 新型抗病毒化合物 Novel antiviral compounds
05/23/2012CN102464653A 具有杀虫活性的偶氮杂环化合物、其制备及用途 Azo-heterocyclic compounds having pesticidal activity, their preparation and use
05/23/2012CN102464652A Imidazole derivative and preparation method as well application
05/23/2012CN102464621A 含嘧啶环的醚类化合物及其应用 Ether compounds containing a pyrimidine ring and its applications
05/23/2012CN102464612A 含哌嗪氨基甲酸酯的二卤丙烯醚类化合物与应用 Piperazine-containing urethane-dihalo ether compound of propylene and Applications
05/23/2012CN102464611A Substitutional biaryl base benzene sulfonamide compound and application
05/23/2012CN102464608A Compound and application thereof as L-calcium channel retarder or/and acetylcholinesterase inhibitor
05/23/2012CN102464592A 酰基苄胺类化合物及其应用 Acyl, benzyl amine compounds and their application
05/23/2012CN101628888B Inhibitors of cytosolic phospholipase a2
05/23/2012CN101511789B 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists
05/23/2012CN101490006B Biarylcarboxyarylamides as vanilloid-1 receptor modulators
05/23/2012CN101429191B Uses of substituted tetrahydrochysene isoquinoline derivant
05/23/2012CN101203507B 2-substituted benzimidazoles
05/23/2012CN101155800B Pyrazolylaminopyridine derivatives useful as kinase inhibitors
05/23/2012CN101142208B 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication
05/23/2012CN101061098B Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/23/2012CN101012141B Method of manufacturing chiral sulfoxide compounds
05/22/2012US8183383 Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof
05/22/2012US8183381 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
05/22/2012US8183374 Piperidine and piperazine derivatives
05/22/2012US8183366 Chemokine receptor antagonists
05/22/2012US8183275 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/22/2012US8183264 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
05/22/2012US8183254 Inhibitors of JNK
05/22/2012US8183253 Condensing (3-trifluoromethylsulfonyl) benzoyl chloride and 4-methyl-2-nitro-aniline; reducing nitro group with stannous chloride; condensing amino group with cyanamide; cyclocondensing guanidine group with 3-dimethylamino-1-pyridin-3-yl-propenone; antiproliferative agents; chronic myeloid leukemia
05/22/2012US8183242 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
05/22/2012US8183239 Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor
05/22/2012US8183238 Bicyclic and tricyclic compounds as KAT II inhibitors
05/22/2012US8183235 Dihydronaphthalene compound and use thereof
05/22/2012CA2624045C Process for the manufacture of quinazoline derivatives
05/22/2012CA2560642C 5-aminoalkylpyrazole derivatives as pesticidal agents
05/22/2012CA2540501C Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
05/22/2012CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands
05/18/2012WO2012064943A2 Metalloenzyme inhibitor compounds
05/18/2012WO2012064808A1 Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses
05/18/2012WO2012064805A1 Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
05/18/2012WO2012064631A1 Pyridyl ureas as mineralocorticoid receptor antagonists
05/18/2012WO2012064559A1 Sgc stimulators
05/18/2012WO2012064548A1 Compounds useful for inhibiting chk1
05/18/2012WO2012063896A1 Novel pyrazole amide derivative
05/18/2012WO2012063207A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012WO2012062844A1 Novel microbiocides
05/18/2012WO2012062783A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012WO2012062704A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
05/18/2012WO2012062687A1 Triazole derivatives and their use for neurological disorders
05/18/2012WO2012062463A1 Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012WO2012062462A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012WO2012062210A1 Compound for increasing kinase active and application thereof
05/18/2012WO2012062187A1 Prolinamide derivative as thrombin inhibitor, preparation method and application thereof
05/18/2012WO2012061926A1 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
05/18/2012WO2012037411A9 Estrogen receptor modulators and uses thereof
05/18/2012WO2012024620A3 Autotaxin inhibitors and uses thereof
05/18/2012WO2012012410A3 Kappa opioid receptor agonists
05/18/2012WO2012003418A3 Functionally selective ligands of dopamine d2 receptors
05/18/2012WO2011139107A3 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
05/18/2012CA2817691A1 Metalloenzyme inhibitor compounds
05/18/2012CA2817577A1 Heterocyclic compounds and uses thereof
05/18/2012CA2817319A1 Sgc stimulators
05/18/2012CA2816944A1 Compounds useful for inhibiting chk1
05/18/2012CA2816804A1 Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012CA2816769A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012CA2816753A1 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
05/18/2012CA2816000A1 Drug derivatives
05/18/2012CA2815839A1 Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
05/18/2012CA2815742A1 Novel microbiocides
05/18/2012CA2815330A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
05/18/2012CA2815179A1 Lactam derivatives useful as orexin receptor antagonists
05/18/2012CA2812669A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012CA2812667A1 Triazole derivatives and their use for neurological disorders
05/17/2012US20120123126 Compounds As c-Met Kinase Inhibitors
05/17/2012US20120123115 Cyclic guanidine ionic liquid
05/17/2012US20120123114 Quinazoline derivatives having tyrosine kinase inhibitory activity
05/17/2012US20120123113 Di-substituted pyridinum polymers and synthesis thereof
05/17/2012US20120122933 Compounds
05/17/2012US20120122931 Indole derivative or pharmaceutically acceptable salt thereof
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122928 Heteroarylpiperidine and -Piperazine Derivatives as Fungicides
05/17/2012US20120122926 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122902 Pyrimidine derivative, preparation method and use thereof
05/17/2012US20120122892 Chemical compounds
05/17/2012US20120122885 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122867 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
05/17/2012US20120122865 Isoindoline compounds and methods of their use
05/17/2012US20120122864 Inhibitors of hcv ns5a
05/17/2012US20120122857 Heterobicyclic carboxamides as inhibitors for kinases
05/17/2012US20120122854 Carbocyclic Fused Cyclic Amines
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122848 (+)-3-hydroxymorphinan derivatives as neuroprotectants
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122839 Novel pyrrolidin-2-ones
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120122708 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for the identification of biological and pharmacological activity
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 1080